Coherence for Health Innovation for New Medicines for Infectious Diseases

In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for the...

Full description

Bibliographic Details
Corporate Author: Organisation for Economic Co-operation and Development
Format: eBook
Language:English
Published: Paris OECD Publishing 2009
Series:The Development Dimension
Subjects:
Online Access:
Collection: OECD Books and Papers - Collection details see MPG.ReNa
LEADER 01808nmm a2200313 u 4500
001 EB000319202
003 EBX01000000000000000156415
005 00000000000000.0
007 cr|||||||||||||||||||||
008 120214 ||| eng
020 |a 9789264060166 
245 0 0 |a Coherence for Health  |h Elektronische Ressource  |b Innovation for New Medicines for Infectious Diseases  |c Organisation for Economic Co-operation and Development 
260 |a Paris  |b OECD Publishing  |c 2009 
300 |a 148 p.  |c 16 x 23cm 
505 0 |a Annex A -- Annex C -- Neglected and Emerging Infectious Diseases -- Present Policy Solutions Being Used to Address the Problems of Neglected Infectious Diseases -- Annex D -- Annex B -- Acronyms and Abbreviations -- What Are the Problems? -- Moving Forward 
653 |a Social Issues/Migration/Health 
653 |a Science and Technology 
653 |a Development 
710 2 |a Organisation for Economic Co-operation and Development 
041 0 7 |a eng  |2 ISO 639-2 
989 |b OECD  |a OECD Books and Papers 
490 0 |a The Development Dimension 
028 5 0 |a 10.1787/9789264060166-en 
856 4 0 |a oecd-ilibrary.org  |u https://doi.org/10.1787/9789264060166-en  |x Verlag  |3 Volltext 
082 0 |a 333 
082 0 |a 304 
082 0 |a 610 
082 0 |a 600 
520 |a In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for these diseases. This book looks at ways of improving the availability of medicines for infectious diseases through strengthened coherence in health, trade, science and technology, development co-operation and finance